In the preclinical course of Alzheimer’s disease, tau-pathology spreads from perirhinal and entorhinal subregions to hippocampal subfields and amygdala and later to lateral temporal, frontal, and midline parietal regions [22, 63]. The gene discussed is MAPT; the disease is Alzheimer disease.